ehealth-strategien im Wettbewerb: Erfolgsfaktor oder schmückendes Beiwerk? ehealth Kongress Darmstadt, 17 Oktober 2014
|
|
- Barnaby Harrison
- 6 years ago
- Views:
Transcription
1 ehealth-strategien im Wettbewerb: Erfolgsfaktor oder schmückendes Beiwerk? ehealth Kongress Darmstadt, 17 Oktober 2014
2 Health care is in the middle of a perfect storm Changing demographics Unmet needs 1.5 billion over-65s by billion spent on chronic disease in EU Unsustainable growth in health care spending 14% of GDP by 2060, up from 6.2% in the 00s Health care reforms Cost containment initiatives Pricing pressures on the industry Page 2
3 How are different health care stakeholders responding to this shift? Information companies Employers Payers Pharmacies Life sciences Food Co Telcos Social media Consumer electronics Retailers HIT Co Providers Medtechs Distributors Page 3
4 By forming a new health ecosystem, with the patient at the centre HIT companies Payers Medical technology companies Social media companies Patient data Financing Risk sharing Remote care Telecom companies Community engagement Diagnostics Families & friends Social support Connectivity Employers Information companies Health literacy Providers Medical expertise Nutrition Functional Foods Self-managed patient Access Behavioral change Counseling Drugs Efficacy insights Life sciences Pharmacies Food companies Retailers Consumer electronics Page 4
5 The pace of change is accelerating 3-5 years ago Today 3-5 years from now Early debate, uncertainty about move to value Most people had never heard of big data Wearable technologies were novelties Much data (on cost, quality, relationships, clinical trials etc) was opaque Sweeping reforms in US, Germany, France, UK, others all based on value Growing number of analytics initiatives with large amounts of diverse data Increasingly common; Unobtrusive, noninvasive; payers starting to pay Transparency (apps, govt. initiatives, industry responses) Pay for performance and specialty drug prices put pressure on drug cost increases Real-world data, prescriptive analytics: less ability for pharma s to control the message Drugs increasingly compete with non-drug interventions Transparency scrutiny, pressure. Trust is a source of competitive advantage Page 5
6 59% of business decision-makers use customer generated data for customer insight 80% of organizations are in the early stages of big data initiatives Big data is expected to boost global retail and manufacturing revenues by $325 billion Every minute 208,300 photos are uploaded to Facebook 79% of businesses believe that big data will boost revenue Every minute 350,000 Tweets are posted on Twitter 71% of executives are not concerned that customers may start to restrict the use of personal information 70% of consumers are never happy for companies to share their personal data 49% of consumers say that they will be less willing to share personal information in the next five years The volume of data will exceed to 40 zettabytes by 2020
7 The patient-centric information exchange: Health care everywhere Healthcare Analytics Portable Medical Devices Wearable Devices Consumerized medical devices Patient Medicalized consumer products Telehealth Online Communities Mobile Apps Page 7
8 Inefficiency is a major driver in better use of data One-third of US health care spending is wasted every year Unnecessary services Administrative costs Inefficient delivery of care Inflated prices Fraud Failure to prevent disease US$750 billion Source: Institute of Medicine Report (September 2012) Page 8
9 Connecting a complex network Patients Providers Corporations Payers Authorities Wellness & prevention Patient information Integrated health care information platforms Patient records Health information exchanges (HIEs) Increased health care access Empowered patient Individual treatment Home care Health care analytics Digital assistants Health care anywhere propositions Cost-effective treatment Information integration services Mobile health care devices Cost-effective health care Reimbursement strategy Fraud detection Health care analytics Health insurance exchange (HIX) National health records Compliance Cloud and connectivity: Information flow between the stakeholders is key to ensure better outcomes Page 9
10 Data are being used in creative ways to address behavioural issues Non-adherence leads to US$290 billion in direct and indirect health costs annually 13% of total US health care expenditures Pfizer/Keas Pfizer uses Keas platform to develop personalized online care plans for users. Keas website motivates employees with points, badges, and feedback from co-workers 50% Decrease in at-risk patients Novartis Get On Track Educational material, customized lifestyle plans and reminders to help hypertension patients manage their conditions. 31% Improved adherence vs. not enrolled Page 10
11 The path to navigating data complexity Pooling data Purchasing data Partnerships to share data, co-develop insights Creating the full picture Algorithms to match data, even without identifier information Breadth (more variables) matters more than depth (more patients) Identifying the data that matters 80/20 rule Driving timely interventions Behavioral interventions Predictive analytics What-if experiments Not just correlation causality Prescriptive analytics Page 11
12 Europe Examples of e-health Initiatives Europe 2012: Launch of ehealth Action Plan Roadmap to empower patients and healthcare workers, to link up devices and technologies, and to invest in research towards the personalised medicine of the future United Kingdom 2011: ehealth Strategy launched 3 million lives (3ML) campaign use of telecare and telehealth technology for improving the lives of at least three million people over the next five years; expected to save GBP1.2bn a year. France 2010: Development Plan for the Digital Economy In 2010, France invested EUR 3 m for telematic projects; reimbursement of telemedicine services is at the same levels as those for in-person visits Germany 2010: National ehealth Initiative launched Use of electronic health card and telematics infrastructure; for 2014 Health Minister has announced ehealth law Spain : Sanidad en Linéa program Investment of 196 million to support projects, such as digital medical records, eprescribing, the doctor s appointment system Italy 2012: Launch of egov2012 action plan ehealth with a budget allocation of EUR329 million is included as a key pillar Page 12
13 Government-led digital health integration in Germany Mega trends and market opportunities Government drives health integration German government ehealth program Health reform (DRGs, Mega GMG) trends Large ehealth deals Application integration Large-scale service operation Industrialization of hospitals Standardization of clinical processes Evolution of chains Concentration on core business Standardization and integration of health insurers Evolution of standardized IT systems Claims management becomes key in coping with health care complexity Conservative business Hospital transformation CIS, SAP implementation BPO / ITO deals Health insurance transformation SAP platform in health insurance Health data management Integrated care Page 13
14 Continue the conversation Christian Egle Partner Healthcare Advisory Lead Ernst & Young GmbH Tel Mobile Progressions 2014 Navigating the payer landscape Health care industry report Voyage to value Beyond borders 2014 Global biotech report Unlocking value Pulse of the industry 2014 Medical technology report Differentiating differentiation Page 14
YASHAJIT SAHA & ABHISHEK SHARMA, SUBJECT MATTER EXPERTS, RESEARCH & ANALYTICS ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN PHARMA.
YASHAJIT SAHA & ABHISHEK SHARMA, SUBJECT MATTER EXPERTS, RESEARCH & ANALYTICS ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN PHARMA wns wns ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN
More informationMaximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS
Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS by Jan Nielsen, division president, Access & Patient Support Are You Asking the Right Questions? We ve all
More informationFOCUS REIMBURSEMENT STRATEGY TO DEMONSTRATE FULL VALUE STORY
WHITE PAPER FOCUS REIMBURSEMENT STRATEGY TO DEMONSTRATE FULL VALUE STORY By Nicole May, Research Analyst at Cutting Edge Information OVERVIEW National and private payers, especially in the US and EU, are
More informationHealthcare Payers: In Pursuit of Four Digital Objectives
White paper Healthcare Payers: In Pursuit of Four Digital Objectives Manoj Narayan Abstract Today, the healthcare industry is undergoing a significant change. Consumers are technologically savvy and expect
More informationThe Future of Market Access A FirstWord ExpertViews Dossier Report
AM PL E PA G ES S A G ES S A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or used in
More informationPharma R&D and Patents support Health Care & Economy
Pharma R&D and Patents support Health Care & Economy Konstantinos Μ. Frouzis President of SFEE, V.P & Gen. Manager of Novartis Hellas April 28 th, 2014 Intellectual Property Patents: The vehicle for innovation
More informationPharmamarketing - strategic challenges
Pharmamarketing - strategic challenges Biomedicine Master Program Lund University Course: Biomedicine the Profession Anna Chérouvrier Hansson, MSc. December 16th, 2014 1. Pharmamarketing - definitions
More informationDEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE
CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE WHEN COMMERCIALIZING A MEDICINE, IT
More informationThe importance of regulatory science in a societal and industrial perspective Annual Conference CORS 24 November 2016
The importance of regulatory science in a societal and industrial perspective Annual Conference CORS 24 November 2016 Marianne Kock, Head of Global Regulatory Affairs & Managing Director, Ferring Pharmaceuticals
More informationIT Outsourcing (ITO) in the Healthcare Provider Industry Annual Report 2015: Building a Coherent Value Proposition
IT Outsourcing (ITO) in the Healthcare Provider Industry Annual Report 2015: Building a Coherent Value Proposition Healthcare & Life Sciences IT Annual Report: January 2016 Preview Deck EGR-2016-12-PD-1674
More informationBIOTECH, MED DEVICE & PHARMA
WHITEPAPER Key Account Management Strategies for BIOTECH, MED DEVICE & PHARMA INTRODUCTION Changes in the healthcare landscape have led to changes in customers. In an environment where healthcare providers
More informationPharma Medical Affairs 2020 and beyond. Matthias Evers Edd Fleming Arnab Ghatak Jan Hartmann Arif Nathoo Ron Piervincenzi Lawrence Wai Ann Westra
Pharma Medical Affairs 2020 and beyond Matthias Evers Edd Fleming Arnab Ghatak Jan Hartmann Arif Nathoo Ron Piervincenzi Lawrence Wai Ann Westra A rapidly changing world for Medical Affairs Pharma s Medical
More informationInsights into the Evolving Pricing & Market Access Environment
Insights into the Evolving Pricing & Market Access Environment UBC Global Market Access Survey July 2012 JULY 2012 GLOBAL MARKET ACCESS SURVEY UBC s Global Market Access Survey: Setting the Stage For those
More informationShifting Pharma Sales Models. Text for a pull out can go heretext for a pull out can go heretext for a pull out can go
Text for a pull out can go heretext for a pull out can go heretext for a pull out can go Text for a pull out can go here Text for a pull out can go here Shifting Pharma Sales Models to Focus on Providing
More informationThe Innovative Medicines Initiative: Building new models of collaborative research across Europe
The Innovative Medicines Initiative: Building new models of collaborative research across Europe Elisabetta Vaudano IMI, Belgium www.imi.europa.eu What is IMI? An European Public-Private Partnership Focused
More informationNew Frontiers in Personalized Medicine
New Frontiers in Personalized Medicine Oracle Open World Shanghai 2013 Neil de Crescenzo SVP and GM 1 Safe Harbor Statement The following is intended to outline our general product direction. It is intended
More informationMapping the Patient Journey: Harnessing the power of big data and analytics A FirstWord ExpertViews Dossier Report
AM PL E PA G ES S A S G ES data and analytics A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced
More informationBUILDING REVENUE AND LOYALTY WITH DIGITAL HEALTH. London, April 4-5.4, 2017 Janne-Olli Järvenpää, CEO Mehiläinen Oy
BUILDING REVENUE AND LOYALTY WITH DIGITAL HEALTH London, April 4-5.4, 2017 Janne-Olli Järvenpää, CEO Mehiläinen Oy ABOUT MEHILÄINEN DIGITAL PATIENT PATHWAY DIGITAL OCCUPATIONAL HEALTHCARE WHAT HAPPENS
More informationProject Financing Models
Project Financing Models Implementation of an e-passport or eid card can cost $ millions. There are 3 ways for a Government to allocate the budget: Direct Payment BOT (Build-Operate-Transfer) PPP (Public-Private
More informationHealth Solutions. Commercial Health Solutions Overview EXPANDING INSIGHT. ENSURING VALUE. IMPROVING OUTCOMES.
Health Solutions Commercial Health Solutions Overview EXPANDING INSIGHT. ENSURING VALUE. IMPROVING OUTCOMES. Expanding Insight. Ensuring Value. Improving Outcomes. Organizations look to experienced solutions
More informationIntegrated Care Information Management Readiness. An IDC InfoBrief, Sponsored by Dell EMC October 2016
Integrated Care Information Management Readiness Dell EMC October 2016 Introduction Dell EMC asked IDC Health Insights to analyze the progress of digital transformation in the health industry in the U.K.
More informationNew WHO Report: Access to new medicines in Europe: Technical review of policy initiatives and opportunities for collaboration and research
New WHO Report: Access to new medicines in Europe: Technical review of policy initiatives and opportunities for collaboration and research Hanne Bak Pedersen Programme Manager Health Technologies and Pharmaceuticals
More informationA High-Touch Approach to Improving Patient Access. Using field support to navigate reimbursement challenges
A High-Touch Approach to Improving Patient Access Using field support to navigate reimbursement challenges For the brand and reimbursement teams who must develop commercial strategies for the biopharmaceutical
More informationHealthcare & Lifesciences Whitepaper
Healthcare & Lifesciences Whitepaper 1 Introduction Healthcare and Life Sciences (HLS) organizations are committed towards enhancing the lives and well-being of people around the world. They have not been
More informationCRO partner in Rx/CDx Co-Development
CRO partner in Rx/CDx Co-Development DEDICATED DIALOGUE A sponsored roundtable discussion published in Pharmaceutical Executive Two Covance executives discuss a CRO s role in supporting Companion Diagnostics
More information13 15 SEPTEMBER 2017 SERVING LABORATORY MANAGEMENT & DIOGNOSTIC NETWORKS GLOBALLY BARCELONA CONGRESS CENTRE, BARCELONA, SPAIN
13 15 SEPTEMBER 2017 BARCELONA CONGRESS CENTRE, BARCELONA, SPAIN SERVING LABORATORY MANAGEMENT & DIOGNOSTIC NETWORKS GLOBALLY www.medlabeurope.com medlabeurope@informa.com +34 518890041 INTRODUCTION It
More informationEMPLOYER BEST PRACTICES IN TELEHEALTH
EMPLOYER BEST PRACTICES IN TELEHEALTH Overview The rapid adoption of telehealth that started in 2010 has been driven not by healthcare providers, but instead by employers, seeking to address two of healthcare's
More informationVISIO MOBILE DIAGNOSTICS ROLLS OUT COMPUMED'S EHEALTH TECHNOLOGY TO MARKETS ACROSS OHIO
VISIO MOBILE DIAGNOSTICS ROLLS OUT COMPUMED'S EHEALTH TECHNOLOGY TO MARKETS ACROSS OHIO LOS ANGELES, May 27, 2010 -- CompuMed, Inc. (http://www.compumed.net), a telemedicine and medical informatics company,
More informationWHITE PAPER. Engaging the Evolving Stakeholder Network: A New Approach for Medical Affairs
Engaging the Evolving Stakeholder Network: A New Approach for Medical Affairs 1 Executive Summary In today s complex healthcare landscape, the success or failure of a new therapeutic intervention depends
More informationThe Competition Council launched for public consultation the report on sector inquiry on pharma market
The Competition Council launched for public consultation the report on sector inquiry on pharma market One of the conclusions of the sector inquiry on pharma sector carried out by the Competition Council
More informationOptum Performance Analytics
Optum Performance Analytics A unified health care data and analytics platform Photo to come Optum Performance Analytics Position your organization for success with Optum Performance Analytics Dynamic health
More informationNew Cardinal Health (Post-Spin)
New Cardinal Health (Post-Spin) George Barrett Vice Chairman and Chief Executive Officer Healthcare Supply Chain Services and Chief Executive Officer Cardinal Health, Inc. (post-spin) January 14, 2009
More informationLife Sciences Practice
Life Sciences Practice The healthcare landscape has recently experienced considerable changes, including highly visible public demands for safer and improved healthcare systems. At the core of this is
More informationBusiness Analytics and Optimization An IBM Growth Priority
Business Analytics and Optimization An IBM Growth Priority Paul Fitzpatrick Director, WW Industry ISV Partners IBM ISV & Developer Relations Best Student Recognition Event July 6-8, 2011 EMEA IBM Innovation
More informationHealthcare s New Change-Maker: The CFO
The role of hospital chief financial officer has changed dramatically over the last 50 years. No longer simply responsible for managing the hospital s finances, today s CFO is a change agent, an indispensable
More informationAIT Austrian Institute of Technology
AIT Austrian Institute of Technology Expert view of Biomedical Engineering and Care Services Brussels,, 09:30 a.m. to 13:00 p.m. EESC, Jacques Delors Building, Room JDE 61, rue Belliard 99 Manfred Bammer,
More informationIDC Market Glance: Value-Based Health
IDC Market Glance: Value-Based Health Jonas Knudsen IDC A change in paragime major trends Personalization Integration Value IDC Visit us at IDC.com and follow us on Twitter: @IDC 2 Organizations are Facing
More informationHow to Make IT the Underpinning of the Enterprise Strategy
How to Make IT the Underpinning of the Enterprise Strategy Session #146 February 22, 2017 1 John Ward, CIO TriHealth Bob Schwyn, Director The Chartis Group Speaker Introductions John Ward, CIO Chief Information
More informationVALUE-BASED HEALTHCARE A MANUFACTURER S PERSPECTIVE PETER JUHN, MD, MPH VICE PRESIDENT AND GLOBAL HEAD, VALUE-BASED PARTNERSHIPS
VALUE-BASED HEALTHCARE A MANUFACTURER S PERSPECTIVE PETER JUHN, MD, MPH VICE PRESIDENT AND GLOBAL HEAD, VALUE-BASED PARTNERSHIPS NATIONAL CONFERENCE OF STATE LEGISLATURES SAN DIEGO, CA DECEMBER 10, 2017
More informationGlobal Forum on Competition
Unclassified DAF/COMP/GF/WD(2014)51 DAF/COMP/GF/WD(2014)51 Unclassified Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development 14-Feb-2014 English
More informationUsing local RWD to drive global therapeutic advancements.
Using local RWD to drive global therapeutic advancements. Helsinki, 30 th Nov 2016 Mike Spencer, Head of Real World Evidence, EMEA, Janssen The following represent my own views and not necessarily those
More informationLife Sciences Supply Chain Benchmarking Survey 2015
Knowledge Partner Life Sciences Supply Chain Benchmarking Survey 2015 www.deloitte.co.uk INTRODUCTION What are the key trends developing in pharma supply chain, and how are the industry s most prominent
More informationHEALTHCARE. Advanced Costing Techniques to Improve Service Line Decision Making
HEALTHCARE Advanced Costing Techniques to Improve Service Line Decision Making Introduction The role of cost accounting in healthcare Healthcare s new value-based business model requires that providers
More informationFuture Pharma - Challenges & Trends MES Process & Minds Conference Berlin, Germany, September 2015
Future Pharma - Challenges & Trends MES Process & Minds Conference Berlin, Germany, 28-29 September 2015 (PhD) Agenda Key challenges facing the Pharmaceutical Industry 1. Delivering shareholder/stakeholder
More informationHealthcare Provider IT Services Service Provider Landscape with Services PEAK Matrix Assessment 2017
R Healthcare Provider IT Services Service Provider Landscape with Services PEAK Matrix Assessment 2017 Focus on Optum December 2017 Copyright 2017 Everest Global, Inc. This document has been licensed for
More informationPlanning for Successful Medical Device Reimbursement:
Planning for Successful Medical Device Reimbursement: So Your Device Is Cleared, By Tiffini Diage, MPH Health Economics NAMSA White Paper Key Considerations for Targeting Success of Medical Device Sales
More informationICT: Building for the future
ICT: Building for the future Dr Pete Sudbury Healthcare Specialist, HP Enterprise Services Pete Thackery Head of Healthcare & Life Sciences, HP Enterprise Services Agenda Context The prize: Digital health
More informationEU health policy. Strategy for the pharmaceutical industry and biosimilars. Salvatore D'Acunto. DG Research. DG Internal Market. DG Health & Consumers
Strategy for the pharmaceutical industry and biosimilars Salvatore D'Acunto European Commission Enterprise and Industry Directorate-General London, 3 April 2014 EU health policy DG Research R&D, innovation
More informationWe've all heard the dismal statistics: 10,000 known diseases with only 500 treatments. Not great odds if you're a patient.
No longer just passengers, patients are now co-pilots helping to navigate the future of medical progress. But until recently, the pace of progress has been slow. In some diseases, we still utter the words
More informationSOCIAL MEDIA STRATEGY. Creating Culture Making Impact Digital Transformation Stakeholder Engagement
SOCIAL MEDIA STRATEGY Creating Culture Making Impact Digital Transformation Stakeholder Engagement HSE November 2017 Introduction The Digital Age has transformed communications as we know it. Marketing
More informationJohnson & Johnson s trusted and experienced guide. to patient adherence and acquisition
Johnson & Johnson s trusted and experienced guide to patient adherence and acquisition You may know us as the largest distributor of pharmaceutical products or as the leader in co-pay cards and alternative
More informationSection I: Pharmaceuticals and Medical Devices
SUPPLEMENT on HEALTHCARE INNOVATION Visionary Goals and Recommendations 51th Japan-U.S. Business Conference Japan-U.S. Business Council / U.S.-Japan Business Council November 14, 2014 The R&D-based pharmaceutical
More informationTrinity ConTRact: Cornerstone Projects in Contracting Strategy
Trinity ConTRact: Cornerstone Projects in Contracting Strategy With mounting external pressures limiting access and tightening reimbursement, effective contracting is critical to the commercial success
More informationBIOTECH IN FRANCE. key info in. points
BIOTECH IN FRANCE 10 key info in points 1 2 3 INSERM: EUROPE S #1 ACADEMIC BIOTECH RESEARCH INSTITUTE INSERM spearheads healthcare and medical research in France, filing more biotech patents with the European
More informationIDC MarketScape: Worldwide Life Science Sales and Marketing Digital Transformation 2016 Vendor Assessment
IDC MarketScape IDC MarketScape: Worldwide Life Science Sales and Marketing Digital Transformation 2016 Vendor Assessment Michael Townsend THIS IDC MARKETSCAPE EXCERPT FEATURES: COGNIZANT IDC MARKETSCAPE
More informationDIGITAL EDITION BONUS CONTENT
DIGITAL EDITION BONUS CONTENT Denise Myshko Forecasting Pharma s Future Given the volatility of today s financial landscape, c ompanies, more than ever, need a robust forecasting strategy that is clear,
More informationFactors Supporting a Sustainable European Biosimilar Medicines Market PROJECT SUMMARY FOR EXTERNAL COMMUNICATION
Market Access Factors Supporting a Sustainable European Biosimilar Medicines Market PROJECT SUMMARY FOR EXTERNAL COMMUNICATION A study undertaken by GfK Market Access on behalf of the European Biosimilars
More information2017 Precision Medicine Study
2017 Precision Medicine Study www.himssanalytics.com Enabling better health through information technology. Precision Medicine Study Introduction DNA genetic testing companies such as Ancestry.com and
More informationEmployee Engagement. Larry S. Boress President and CEO Midwest Business Group on Health
Zoomerang Identifying the Slide Triggers Presentation and Barriers to Employee Engagement Larry S. Boress President and CEO Midwest Business Group on Health Overview: Midwest Business Group on Health A
More informationDigitally Connected RAIN Embedded Solutions for IoT Eric Wood, VP Product Management, Printed Electronics
Digitally Connected RAIN Embedded Solutions for IoT Eric Wood, VP Product Management, Printed Electronics That s quite a mouthful what does it mean? Digitally Connected Information is available when needed
More informationHow can pharma outsourcing partners overcome the challenges of a rapidly changing industry?
How can pharma outsourcing partners overcome the challenges of a rapidly changing industry? ADAPTING TO CHANGE IN CONTRACT PHARMA How can pharma outsourcing partners overcome the challenges of a rapidly
More informationWhitepaper. Hexaware's Accelerators for Facets- A Health Plan Administration Platform. Published on: October 2011 Author: Saurabh Maheshwari
Published on: October 2011 Author: Saurabh Maheshwari Hexaware Technologies. All rights reserved. Table of Contents 1 Introduction 2 Abstract 3 Key Challenges in Healthcare Market 4 Product Capabilities
More informationProject Destiny Summary
Project Destiny Summary The American Pharmacists Association (APhA), the National Association of Chain Drug Stores (NACDS), and the National Community Pharmacists Association (NCPA) have joined together
More informationIntroduction. Context for Digital Transformation. Customer Experience
Introduction The last decade has seen a massive shift in our economy and we are starting to see entire industries disrupted and transformed. Business models that were stable for decades or centuries have
More informationOur Uncertain but Bright Healthcare Future. Jennifer Searfoss, Esq., CPOM, CHCI, CMCS o e
Our Uncertain but Bright Healthcare Future Jennifer Searfoss, Esq., CPOM, CHCI, CMCS o 888 886 8054 e jen@scghealth.com About Jennifer Jennifer Searfoss, Esq., CPOM, CHCI, CMCS is the CEO of the Searfoss
More informationCIO - Chief Innovation Officers Igniting Innovation & Exponential Growth through Digital Transformation. Osama Al-Zoubi CTO CISCO ME
CIO - Chief Innovation Officers Igniting Innovation & Exponential Growth through Digital Transformation Osama Al-Zoubi CTO CISCO ME In 10 years, it s predicted that 40%+ of Enterprise companies will no
More informationTALENT STRATEGY AN INTEGRAL PART OF BUSINESS STRATEGY AT GENERALI
TALENT STRATEGY AN INTEGRAL PART OF BUSINESS STRATEGY AT GENERALI BERLIN, 21MAY 2015 Christina Anagnostopoulou Generali Group Talent Management GENERALI S CONCEPTUAL FRAMEWORK Diagnostic People Strategy
More informationHealth Systems Engineering Call to action
Health Systems Engineering Call to action APICS DC Metro Chapter Presenters: Satish Gattadahalli and Bill Barton Date: July 21, 2015 Property of Whitney, Bradley & Brown, Inc. 2012. WBB s practices for
More informationSAMPLE. Bracco Imaging S.p.A.Market Share Analysis. Bracco Imaging S.p.A. Market Share Analysis GDME0639CDB / Published January 2013
Market Share Analysis Reference Code: GDME0639CDB Publication Date: January 2013 GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 1 Table
More informationАптечная сеть АСНА. Pharmacy chain ASNA. Kondratev Alexander Managing Partner, ASNA
Аптечная сеть АСНА Pharmacy chain ASNA 16.05.2015 Kondratev Alexander Managing Partner, ASNA Kate Kondrateva 4 years (2006) Why the sky is blue? Why plane is flying, but don t flap the wings? Why I am
More informationISV CLUB. Facing Market Shift: IBM Vision DEVELOPPEZ VOTRE ECOSYSTEME ET DECOUVREZ DE NOUVELLES OPPORTUNITES. IBM Bois Colombes
Facing Market Shift: IBM Vision IBM Bois Colombes 15 Juin 2015 Hubert lalanne DE IBM Analytics #ibmcommerce #ibmanalytics 2015 IBM Corporation Since 2014, Mobile is most commonly used than Web over the
More informationControl Costs and Increase Employee Engagement With Consumer Advantage
Control Costs and Increase Employee Engagement With Consumer Advantage Engage Employees Faced with rising healthcare costs, employers are turning to consumer-driven strategies to provide more cost-efficient
More informationthe New Competitive Equation
M a k i n g C u s t o m e r Va l u e C r e a t i o n the New Competitive Equation February 2017 Market Research This presentation explores background research on the Omni-Channel as it relates to the telco
More informationCloudSuite Corporate ebook
CloudSuite Corporate ebook Contents The solution What makes it different? A platform for growth Designed to power your enterprise goals When most people think of ERP systems, words like innovative, fun,
More informationTHE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION
THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION William S. Dalton, PhD, MD AACR April 17, 2016 Designing a Federated Model To Support Research & Healthcare Offices
More informationDigital Physician Relations, Part II
Digital Physician Relations, Part II Lyle Green, MD Anderson April 2015 Setting the Scene The changing role of the physician; less time to interact with patients Physicians less interested in being interrupted;
More informationDigital Skills: The CIO Perspective
Digital Skills: The CIO Perspective E About the research To explore the impact digital skills are having on businesses today, and the role of the CIO in their development, VMware gathered insights from
More informationVIVEK VIKRAM SINGH, SUBJECT MATTER EXPERT, RESEARCH & ANALYTICS CAN COMPETITIVE INTELLIGENCE STRATEGIES HELP IN ORPHAN DRUG DEVELOPMENT?
VIVEK VIKRAM SINGH, SUBJECT MATTER EXPERT, RESEARCH & ANALYTICS CAN COMPETITIVE INTELLIGENCE STRATEGIES HELP IN ORPHAN DRUG DEVELOPMENT? wns wns CAN COMPETITIVE INTELLIGENCE STRATEGIES HELP IN ORPHAN DRUG
More informationA Benefits Partner You Can Be Confident In
A Benefits Partner You Can Be Confident In Your company is unique. So are its employees and financial goals. Traditional, fully-insured health plans aren t always designed with your company s needs in
More informationUniversità Cattolica del Sacro Cuore
Università Cattolica del Sacro Cuore The role of Regulatory Affairs in drug development Francesco Mazza, Director of Legal, Fiscal & Compliance Affairs in Farmindustria Rome, May 12 2017 Who we are Who
More informationPERSPECTIVE. New Frontiers of Growth in the Life Sciences Industry. Abstract. Subhro Mallik
PERSPECTIVE New Frontiers of Growth in the Life Sciences Industry Subhro Mallik Associate Vice President and Head Life Sciences, Americas and Europe, Infosys Abstract The life sciences industry is on the
More informationlearningpeople.co.uk #work2live #RUdigital
Digital marketing is everywhere Our digital marketing training covers search engine optimisation, social media, Google Analytics, pay per click, strategy, planning, email marketing and lots more. Perfect
More informationSUCCESSFUL BRANDS: LATVIA ESTONIA CROATIA GERMANY UNITED KINGDOM BOSNIA-HERZEGOVINA BULGARIA MACEDONIA SERBIA CZECH REPUBLIC SLOVAKIA FRANCE AUSTRIA
ACCESS TO SUCCESS SUCCESSFUL BRANDS: CROATIA ESTONIA LATVIA BOSNIA-HERZEGOVINA BULGARIA MACEDONIA SERBIA GERMANY UNITED KINGDOM SLOVAKIA CZECH REPUBLIC FRANCE HUNGARY AUSTRIA ITALY ACCESS TO OUR MARKETS
More informationPersonalized Medicine
Personalized Medicine Dr. Pablo Mentzinis, Director Government Relations, SAP SE Courtesy by Dominik Bertram, Marc von der Linden, Péter Adorján, SAP June 2016 1. Traditional medicine vs. personalized
More informationDIGITAL TRANSFORMATION IN HEALTHCARE
DIGITAL TRANSFORMATION IN HEALTHCARE Delivering Cost-Effective, High-Value Healthcare with NVIDIA Virtual GPU Solutions Year after year, the healthcare industry is faced with challenges revolving around
More informationMaking the entire pharmaceutical chain sustainable. Bengt Mattson. Policy Manager, LIF (Manager,CSR & Environmental Affairs, Pfizer AB)
Making the entire pharmaceutical chain sustainable Bengt Mattson Policy Manager, LIF (Manager,CSR & Environmental Affairs, Pfizer AB) www.ansvarsblogg.se Twitter: CSRBengt LIF, Feb 15, 2017 Sustainability
More informationHealthcare Expertise for Your Business
Healthcare Expertise for Your Business The Premier Bank Serving Healthcare Businesses in Texas Texas Capital Bank specializes in serving the diverse and complex needs of the rapidly changing healthcare
More informationHealth Reform for New Health Reform Reporters Kaiser Family Foundation July 7, 2016
Transcript provided by the (Tip: Click on the binocular icon to search this document) Health Reform for New Health Reform Reporters July 7, 206 The makes every effort to ensure the accuracy of written
More informationProsci Best Practices in Change Management, 2016 Edition
1000 500 0 Prosci Webinar: New areas of research Prosci Best Practices in Change Management, 2016 Edition New areas of research 1 Prosci Research Foundation 9 studies 17 years 4500 participants What works?
More informationWhy is O2 doing car insurance?
Why is O2 doing car insurance? The reason, and the role of data Steve Wright Head of Product & Operations. O2 Drive Insuretech December 6 th 2016 A bit about O2 You probably know O2 as And we also do this
More informationFour entry strategies for small and midsized companies
White paper >7,100 sales reps >220 product launches in 20 countries supported since 2009 Emerging markets: Four entry strategies for small and midsized companies Executive summary Emerging markets offer
More informationMDM offers healthcare organizations an agile, affordable solution To deliver high quality patient care and better outcomes
MDM offers healthcare organizations an agile, affordable solution To deliver high quality patient care and better outcomes Many healthcare organizations are struggling with rising costs and inconsistent
More informationfor the Smart Economy
18 Blockchain: The Force Multiplier for the Smart Economy 1 The world is filled with inefficiencies 3 DAYS Amount of time to sell a share of stock 12 DAYS Amount of time it takes for a bank to validate
More informationGet started and get better Erwin Taets VIVES Leisure Management Research & Expertise Center
Social Media 2.0 Get started and get better Erwin Taets VIVES Leisure Management Research & Expertise Center VIVES previously known as KATHO new name: VIVES since September 2013 VIVES = you will live in
More informationMass Serialization and Traceability Implementation in the Pharma Industry. Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland
Mass Serialization and Traceability Implementation in the Pharma Industry Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland What drives the industry towards more traceability Strategic
More informationU.S. Hospitals Study Executive Summary
UPS Healthcare Study Executive September 2017 START 2017 Survey 2017 United Parcel Service of America, Inc. 1 An industry facing disruptive change: managing consumerization, clinical outcomes and costs
More information